97 related articles for article (PubMed ID: 22725988)
1. Neuronal immunoexpression and a distinct subtype of adult primary supratentorial glioblastoma with a better prognosis.
Pallud J; Dezamis E; Audureau E; Devaux B; Souillard-Scemama R; Sanai N; Page P; Beuvon F; Koziak M; Oppenheim C; Dhermain F; Schlienger M; Meder JF; Roux FX; Varlet P
J Neurosurg; 2012 Sep; 117(3):476-85. PubMed ID: 22725988
[TBL] [Abstract][Full Text] [Related]
2. Editorial: glioblastoma subtype.
Raffel C
J Neurosurg; 2012 Sep; 117(3):474; discussion 475. PubMed ID: 22725980
[No Abstract] [Full Text] [Related]
3. Outcome and prognostic factors in adult cerebellar glioblastoma.
Babu R; Sharma R; Karikari IO; Owens TR; Friedman AH; Adamson C
J Clin Neurosci; 2013 Aug; 20(8):1117-21. PubMed ID: 23706183
[TBL] [Abstract][Full Text] [Related]
4. Expression of neuronal markers, NFP and GFAP, in malignant astrocytoma.
Hashemi F; Naderian M; Kadivar M; Nilipour Y; Gheytanchi E
Asian Pac J Cancer Prev; 2014; 15(15):6315-9. PubMed ID: 25124617
[TBL] [Abstract][Full Text] [Related]
5. Tumor Location and Survival Outcomes in Adult Patients with Supratentorial Glioblastoma by Levels of Toll-Like Receptor 9 Expression.
Mu L; Wang Y; Wang Y; Zhang H; Shang D; Tan F; Li Y; Chen X
World Neurosurg; 2017 Jan; 97():279-283. PubMed ID: 27744078
[TBL] [Abstract][Full Text] [Related]
6. Expression of diagnostic neuronal markers and outcome in glioblastoma.
Donev K; Scheithauer BW; Rodriguez FJ; Jenkins S
Neuropathol Appl Neurobiol; 2010 Aug; 36(5):411-21. PubMed ID: 20298476
[TBL] [Abstract][Full Text] [Related]
7. Supratentorial glioblastoma treated with radiotherapy: use of the Radiation Therapy Oncology Group recursive partitioning analysis grouping for predicting survival.
Fujii O; Soejima T; Kuwatsuka Y; Harada A; Ota Y; Tsujino K; Sasaki M; Kudo H; Nishihara M; Taomoto K
Jpn J Clin Oncol; 2010 Aug; 40(8):726-31. PubMed ID: 20410057
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
[TBL] [Abstract][Full Text] [Related]
9. New variants of malignant glioneuronal tumors: a clinicopathological study of 40 cases.
Varlet P; Soni D; Miquel C; Roux FX; Meder JF; Chneiweiss H; Daumas-Duport C
Neurosurgery; 2004 Dec; 55(6):1377-91: discussion 1391-2. PubMed ID: 15574220
[TBL] [Abstract][Full Text] [Related]
10. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS
Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534
[TBL] [Abstract][Full Text] [Related]
11. Supratentorial low-grade gliomas in older patients.
Kaloshi G; Psimaras D; Mokhtari K; Dehais C; Houillier C; Marie Y; Laigle-Donadey F; Taillibert S; Guillevin R; Martin-Duverneuil N; Sanson M; Hoang-Xuan K; Delattre JY
Neurology; 2009 Dec; 73(24):2093-8. PubMed ID: 19907009
[TBL] [Abstract][Full Text] [Related]
12. Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide.
Yan T; Skaftnesmo KO; Leiss L; Sleire L; Wang J; Li X; Enger PØ
BMC Cancer; 2011 Dec; 11():524. PubMed ID: 22185371
[TBL] [Abstract][Full Text] [Related]
13. Glioblastoma multiforme in the elderly: a therapeutic challenge.
Mangiola A; Maira G; De Bonis P; Porso M; Pettorini B; Sabatino G; Anile C
J Neurooncol; 2006 Jan; 76(2):159-63. PubMed ID: 16132492
[TBL] [Abstract][Full Text] [Related]
14. The clinicopathologic values of the molecules associated with the main pathogenesis of the glioblastoma.
Kim B; Myung JK; Seo JH; Park CK; Paek SH; Kim DG; Jung HW; Park SH
J Neurol Sci; 2010 Jul; 294(1-2):112-8. PubMed ID: 20441994
[TBL] [Abstract][Full Text] [Related]
15. Treatment Outcome and Prognostic Molecular Markers of Supratentorial Primitive Neuroectodermal Tumors.
Choi SH; Kim SH; Shim KW; Han JW; Choi J; Kim DS; Lyu CJ; Kim JW; Suh CO; Cho J
PLoS One; 2016; 11(4):e0153443. PubMed ID: 27074032
[TBL] [Abstract][Full Text] [Related]
16. The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme.
Shinojima N; Kochi M; Hamada J; Nakamura H; Yano S; Makino K; Tsuiki H; Tada K; Kuratsu J; Ishimaru Y; Ushio Y
J Neurosurg; 2004 Aug; 101(2):219-26. PubMed ID: 15309911
[TBL] [Abstract][Full Text] [Related]
17. Image-guided resection of glioblastoma in eloquent brain areas facilitated by laser surface thermal therapy: clinical outcomes and long-term results.
Rozumenko A; Kliuchka V; Rozumenko V; Semenova V; Kolesnyk S; Fedorenko Z
Neurosurg Rev; 2018 Oct; 41(4):1045-1052. PubMed ID: 29356927
[TBL] [Abstract][Full Text] [Related]
18. Clinical and immunohistochemical prognostic factors in adult glioblastoma patients.
Umesh S; Tandon A; Santosh V; Anandh B; Sampath S; Chandramouli BA; Sastry Kolluri VR
Clin Neuropathol; 2009; 28(5):362-72. PubMed ID: 19788052
[TBL] [Abstract][Full Text] [Related]
19. Supratentorial glioblastoma in adults: identification of subsets and their clinical correlation.
Sarkar C; Sinha S; Sharma MC; Kumar R; Mehta VS
Brain Tumor Pathol; 2004; 21(1):7-12. PubMed ID: 15696962
[TBL] [Abstract][Full Text] [Related]
20. Does high-dose carmustine increase overall survival in supratentorial high-grade malignant glioma? An EBMT retrospective study.
Bay JO; Linassier C; Biron P; Durando X; Verrelle P; Kwiatkowski F; Rosti G; Demirer T;
Int J Cancer; 2007 Apr; 120(8):1782-6. PubMed ID: 17230505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
